Ainos, Inc. (NASDAQ:AIMD) Sees Large Drop in Short Interest

Ainos, Inc. (NASDAQ:AIMD) was the target of a large decrease in short interest during the month of December. As of December 31st, there was short interest totalling 177,100 shares, a decrease of 30.8% from the December 15th total of 255,800 shares. Currently, 4.2% of the shares of the company are sold short. Based on an average daily trading volume, of 534,600 shares, the short-interest ratio is currently 0.3 days.

Ainos Price Performance

Ainos stock opened at $0.65 on Friday. Ainos has a twelve month low of $0.40 and a twelve month high of $3.10. The company’s 50-day moving average price is $0.49 and its two-hundred day moving average price is $0.57. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.37 and a quick ratio of 1.33.

Ainos (NASDAQ:AIMD) last released its quarterly earnings results on Wednesday, November 6th. The company reported ($0.33) earnings per share for the quarter.

Ainos Company Profile

Ainos, Inc, a healthcare company, engages in developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos’ cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a’s broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan.